Blood plasma antiviral process and composition

Details Blood plasma antiviral process and composition Blood plasma antiviral process and composition

1989-11-07

1993-02-16

Rosen, Sam

Drug, bio-affecting and body treating compositions

Extract, body fluid, or cellular material of undetermined...

Blood

424530, 424531, 424533, 514 2, A61K 3516

Patent

active

051869454

ABSTRACT:
The treatment of blood plasma to inactivate or destroy infective viruses, such as the cytomegalovirus CMV, by mixing the plasma with an effective amount of glycyrrhizic triterpenoid compounds is disclosed. Detergents, glycerol or ethylene diamine tetraacetic acid can be added to augment the affect of the glycyrrhizic triterpenoid compounds.

REFERENCES:
Itoh et al.-Chem. Abst. vol. 104 (1986) p. 141, 604C.
Ichikawa et al.-Chem. Abst. vol. 103 (1985) p. 115927v.
Ishida et al.-Chem. Abst. vol. 101 (1984) p. 221,998n.
Pompei et al.-Chem. Abst. vol. 93 (1980) p. 19069w.
Pompei et al.-Chem. Abst. vol. 92 (1980) p. 191170n.

Affiliated with

Also associated with

Rating

Blood plasma antiviral process and composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Blood plasma antiviral process and composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Blood plasma antiviral process and composition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2146941